Japan Has Only Itself To Blame For Decline In Device Applications – AdvaMed
This article was originally published in The Gray Sheet
Executive Summary
The costly and burdensome review process in Japan is responsible for a dramatic decline in device approval applications in recent years, AdvaMed contends in comments to the International Trade Commission